Event
Ensuring European Competitiveness: A Discussion With the Commission, a Rare Disease SME, and a Major Pharma Company
Tuesday, May 20, 2025

Ensuring European Competitiveness: A Discussion With the Commission, a Rare Disease SME, and a Major Pharma Company
Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion about how Europe can stay competitive in view of current challenges and future developments.
SPEAKERS
- Rainer Becker, Director, DG SANTE, European Commission
- Victoria Kitcatt, Vice President and Assistant General Counsel, Head of EU/International Regulatory Law, Pfizer
- Laetitia Szaller, General Counsel, Head of Compliance and ESG, Egetis Therapeutics
A Q&A session will follow the discussion.
AGENDA
5:30 p.m. – Welcome
6:00 p.m. – Panel discussion
7:00 p.m. – Networking reception and canapés
All are invited to attend WLSN events.
関連リソース
関連ブログ
得意分野
Suggested News & Insights
GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Revised EU Product Liability Directive: The Long Read — Scope, Key Changes, and Compliance Implications for Businesses (Part 1)October 21, 2026Sidley Represents Savillex in Its Acquisition of Entegris’ Life Sciences Fluid Management BusinessOctober 20, 2026FDA Announces Rare Disease Framework Initiative to Foster Consistent Review Approach Tailored to Unique Drug Development Considerations for Rare DiseasesOctober 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory